Oculis Holding AG (OCS)
13.09
-0.09
(-0.68%)
USD |
NASDAQ |
Aug 25, 15:38
Oculis 1 Year Total Returns (Daily) : -26.16% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | -26.16% |
| August 21, 2026 | -26.49% |
| August 20, 2026 | -25.13% |
| August 19, 2026 | -24.40% |
| August 18, 2026 | -26.97% |
| August 17, 2026 | -26.59% |
| August 14, 2026 | -27.30% |
| August 13, 2026 | -28.98% |
| August 12, 2026 | -28.86% |
| August 11, 2026 | -29.05% |
| August 10, 2026 | -29.93% |
| August 07, 2026 | -30.33% |
| August 06, 2026 | -31.98% |
| August 05, 2026 | -32.34% |
| August 04, 2026 | -33.17% |
| August 03, 2026 | -32.82% |
| July 31, 2026 | -35.88% |
| July 30, 2026 | -36.77% |
| July 29, 2026 | -40.11% |
| July 28, 2026 | -38.24% |
| July 27, 2026 | -37.78% |
| July 24, 2026 | -36.94% |
| July 23, 2026 | -36.76% |
| July 22, 2026 | -35.17% |
| July 21, 2026 | -31.66% |
| Date | Value |
|---|---|
| July 20, 2026 | -32.97% |
| July 17, 2026 | -32.91% |
| July 16, 2026 | -29.40% |
| July 15, 2026 | -26.66% |
| July 14, 2026 | -28.80% |
| July 13, 2026 | -27.19% |
| July 10, 2026 | -25.92% |
| July 09, 2026 | -25.66% |
| July 08, 2026 | -26.50% |
| July 07, 2026 | -27.64% |
| July 06, 2026 | -27.37% |
| July 02, 2026 | -26.29% |
| July 01, 2026 | -28.64% |
| June 30, 2026 | -28.54% |
| June 29, 2026 | -32.35% |
| June 26, 2026 | -38.40% |
| June 25, 2026 | -39.61% |
| June 24, 2026 | -41.47% |
| June 23, 2026 | -40.36% |
| June 22, 2026 | -39.47% |
| June 18, 2026 | -42.40% |
| June 17, 2026 | -42.73% |
| June 16, 2026 | -40.49% |
| June 15, 2026 | -38.96% |
| June 12, 2026 | -43.65% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Novartis AG | 28.23% |
| Roche Holding AG | 44.96% |
| Addex Therapeutics Ltd. | -53.61% |
| Sandoz Group AG | 47.36% |
| Galderma Group AG | 26.02% |